| [1] |
CHEN Yaozhe, ZHAN Yunli, SONG Xingdong, ZHU Manyu, OU Xuemei, LI Chuyun.
48 Cases of Hematological Adverse Reactions Associated with Piperacillin Sodium and Tazobactam Sodium
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 794-798.
|
| [2] |
CUI Mengyao, LI Shuran, XIE Dan, YANG Xiaowei, LIU Xian, CUI Xiaolan, GENG Zihan, GUO Shanshan.
Research Progress in Antiviral Targets and Active Ingredients of Traditional Chinese Medicine
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 481-487.
|
| [3] |
BAO Lei, GENG Zihan, CUI Xiaolan.
Therapeutic Effect of Shufeng Jiedu Capsules against Respiratory Syncytial Virus-Infected Pneumonia by Regulating AIM2 Inflammasome Pathway
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 495-500.
|
| [4] |
LUO Jianchao, YANG Rong, FU Qiong, LI Jixian.
Effect of Compound Paracetamol Tablets on Plasma Concentrations of Risperidone in Patients with Schizophrenia Complicated with a Cold
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 292-296.
|
| [5] |
FU Xiaoyan, GOU Yu, LUO Xianhai, HU Qiaozhi.
One Case of Anaphylactic Shock Caused by Multiple Oral Cephalexin Capsules Combined with Oolong Tea
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 341-342.
|
| [6] |
NIE Xiaolu, SUN Feng, YAN Aixia, PENG Xiaoxia, ZHAN Siyan.
Methodology for Constructing Benchmark Database of Adverse Drug Reactions Based on Multi-Source Information
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 10-15.
|
| [7] |
NIE Xiaolu, ZHAO Houyu, HUO Donghui, YAN Aixia, SUN Feng, PENG Xiaoxia, NI Xin, ZHAN Siyan.
Pediatric Drug-Induced Immune Thrombocytopenia Based on Real World Data and Quantitative Structure-Activity Relationship
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 16-22.
|
| [8] |
SUN Ximu, ZHOU Han, LI Yanming, GUO Peng, NIE Xiaolu.
Signal Mining and Analysis of ICIs-Associated Thrombocytopenia Adverse Events Based on FAERS Database
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 23-28.
|
| [9] |
SUN Yixin, WANG Chen, YU Yuelin, GUO Peng, NIE Xiaolu.
Safety Surveillance for Vaccine-Induced Immune Thrombotic Thrombocytopenia: a Systematic Review
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 29-36.
|
| [10] |
CHENG Weineng, PAN Qiuna, YANG Jing, FENG Qiang, TANG Xiaomeng, LIANG Yue.
Retrospective Analysis of 763 Cases of Drug Eruptions
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 104-108.
|
| [11] |
DING Yiqiang, LYU Zhiying, LIU Canghai, WEN Qinqin, FANG Xiaoping.
Two Cases of Ceftriaxone Sodium for Injection Induced Immune Hemolytic Anemia in Children
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(11): 1306-1308.
|
| [12] |
LI Jinyang.
Mining of adverse event signals of lamivudine in the kidney and urinary system based on FAERS
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(10): 1154-1158.
|
| [13] |
SHEN Jianghua, KONG Chao, PAN Fumin, CHU Yanqi.
Pharmaceutical care of a case with vertebral osteomyelitis of Coxiella burnetiid
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(10): 1166-1168.
|
| [14] |
ZHANG Hao, CAO Shugang, HE Jun, XU Wenan, XIA Mingwu.
One case of neuromuscular block caused by clindamycin phosphate for injection
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(10): 1178-1180.
|
| [15] |
BAI Xue, TAN Tianyang.
Research progress in reproductive and hepatorenal toxicological mechanisms of Tripterygium wilfordii
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(10): 1192-1199.
|
